Two biologics companies in Minnesota underwent FDA inspections during March, according to the U.S. Food and Drug Administration (FDA).
These inspections represented the smallest number conducted by the FDA for this category of companies in Minnesota, accounting for 11.8% of all inspections in the state that month.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Blood and Blood Products | 2 | — | — |
| Compliance: Devices | — | 2 | — |
| Food Composition, Standards, Labeling and Econ | 2 | — | — |
| Foodborne Biological Hazards | 7 | 3 | — |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 3 | — | — |
| Postmarket Assurance: Devices | 1 | — | — |
